The RASAL2 variant promotes aberrant RAS signaling and resistance to anti-EGFR therapy in colorectal cancer

Y Yu-Min Yeh Y Yi-Hsuan Hsu Y Yi-Ting Huang P Peng-Chan Lin Y Ya-Ting Hsu P Pei-Ying Wu M Meng-Ru Shen

Article Details

Volume / Issue Vol. 15, Issue 1
Published August 23, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

Y

Yu-Min Yeh

Y

Yi-Hsuan Hsu

Y

Yi-Ting Huang

P

Peng-Chan Lin

Y

Ya-Ting Hsu

P

Pei-Ying Wu

M

Meng-Ru Shen